[1]
Nirmal Ahalpara et al. 2025. PHARMACOLOGICAL EVALUATION OF NOVEL INSULIN-DEGRADING ENZYME INHIBITORS IN ALZHEIMER’S DISEASE MANAGEMENT. Journal of Population Therapeutics and Clinical Pharmacology. 32, 8 (Sep. 2025), 1229–1241. DOI:https://doi.org/10.53555/g2qqsc88.